Clinical Trial

Predicting Cancer in Pancreatic Cystic Lesions Through Artificial Intelligence

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 2, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This international, multicenter retrospective study aims to develop a deep learning (DL)-based predictive model to identify malignant transformation in pancreatic cystic lesions, improving upon current clinical guidelines. The model will integrate clinical, biochemical, and multimodal imaging data. Several 3D convolutional neural networks will be trained using advanced preprocessing, data augmentation, and hybrid fusion techniques. Model performance will be compared to that of existing international guidelines. The study involves no additional procedures for patients and adheres to strict data anonymization and privacy regulations.
Trial Details
NCT Number NCT06954753
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Pancreatic Cancer, Pancreatic Cystic Lesions
Enrollment 250 participants
Start Date 2025-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-02